Patents by Inventor Paul Harrington
Paul Harrington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240148217Abstract: A floor cleaning system having a flat headed mop is provided. The system includes a bucket having a wringing assembly. A blade including a first angled portion is provided for that is adjacent a plurality of first openings for compressing the flat headed mop as it is inserted in the wringing assembly to remove dirt and debris accumulated during use. A second angled portion is provided for adjacent a plurality of second openings for compressing the flat headed mop as it is withdrawn from the wringing assembly.Type: ApplicationFiled: December 21, 2023Publication date: May 9, 2024Inventors: Robert F. Smith, Joseph K. Patterson, William Harrington, Paul H. Adams
-
Publication number: 20240084401Abstract: Provided herein, in certain embodiments, are various methods, reagents, and devices for detection of multiple target nucleic acids in a sample, or multiple segments of a target nucleic acid in a sample, using a programmable nuclease. In certain embodiments, the present disclosure provides compositions of pools of guide nucleic acids, programmable nucleases, and detector nucleic acids and methods of using said compositions for detection of different segments of one target nucleic acid or different target nucleic acids in a sample.Type: ApplicationFiled: October 6, 2022Publication date: March 14, 2024Inventors: Matthew VEROSLOFF, Clare FASCHING, Carley Gelenter HENDRIKS, Xin MIAO, James Paul BROUGHTON, Lucas Benjamin HARRINGTON, Janice Sha CHEN
-
Publication number: 20240076875Abstract: A shingle coating asphalt composition is provided that is produced from a paving grade asphalt. The asphalt composition comprises a paving-grade asphalt that has been modified with one or more polymer additives; and a secondary additive comprising one or more of a viscosity reducing agent, a wax, a salt of a fatty acid ester, and an amide of a fatty acid. The shingle coating asphalt coating composition is used to make a shingle. The shingle includes a substrate, the asphalt, and roofing granules.Type: ApplicationFiled: November 8, 2023Publication date: March 7, 2024Inventors: Carmen Anthony LaTorre, Jacob Paul Honsvick, Christopher Patrick Kasprzak, Daniel James Buckwalter, Edward R. Harrington, Jonathan Ross Davis, Laurand Henry Lewandowski, David Michael Ploense, William Edwin Smith, Scott W. Schweiger, Ganesh Latta
-
Patent number: 11539211Abstract: An intelligent impedance injection module is for use with transmission lines in a power grid. The intelligent impedance injection module has a plurality of transformer-less impedance injector units and a controller. The controller changes injector gain of the impedance injector units to compensate for current swings in a transmission line.Type: GrantFiled: April 2, 2020Date of Patent: December 27, 2022Assignee: Smart Wires Inc.Inventor: Paul Harrington
-
Publication number: 20200395756Abstract: An intelligent impedance injection module is for use with transmission lines in a power grid. The intelligent impedance injection module has a plurality of transformer-less impedance injector units and a controller. The controller changes injector gain of the impedance injector units to compensate for current swings in a transmission line.Type: ApplicationFiled: April 2, 2020Publication date: December 17, 2020Inventor: Paul Harrington
-
Patent number: 10206524Abstract: A checkout terminal for customers in a retail store. The terminal provides a path for products from a loading conveyor section, via a scanning section and a common transfer conveyor section, to reach a respective one of a plurality of plurality of packing stations to be bagged or packed by or for the customer. Conveniently, three of these packing stations are arranged substantially parallel to each other. Each packing station may be associated with a corresponding payment interface. Customer throughput is increased by providing multiple packing areas associated with one loading and scanning area, and customer convenience is improved by the faster and more efficient configuration of the checkout terminal.Type: GrantFiled: November 19, 2014Date of Patent: February 19, 2019Assignee: ASDA Stores LimitedInventors: Samantha McPherson, Zoe Brough, Nazim Cheema, Paul Harrington, Sarah Lawson, Paul Dennis
-
Patent number: 9817671Abstract: An extensible software application utilizes rules to initiate a behavior that performs operations that customize the extensible software application in a preferred manner. The behavior is applied when pre-defined events occur during execution of the extensible software application. The rules are provided by a third party developer in metadata that is separate from the extension's program code. The rules are based on expressions that define the events that need to take place during the execution of the extensible software application before the behavior is applied.Type: GrantFiled: June 30, 2014Date of Patent: November 14, 2017Assignee: MICROSOFT TECHNOLOGY LICENSING, LLC.Inventor: Paul Harrington
-
Publication number: 20160270562Abstract: A checkout terminal for customers in a retail store. The terminal provides a path for products from a loading conveyor section, via a scanning section and a common transfer conveyor section, to reach a respective one of a plurality of plurality of packing stations to be bagged or packed by or for the customer. Conveniently, three of these packing stations are arranged substantially parallel to each other. Each packing station may be associated with a corresponding payment interface. Customer throughput is increased by providing multiple packing areas associated with one loading and scanning area, and customer convenience is improved by the faster and more efficient configuration of the checkout terminal.Type: ApplicationFiled: November 19, 2014Publication date: September 22, 2016Inventors: Samantha McPherson, Zoe Brough, Nazim Cheema, Paul Harrington, Sarah Lawson, Paul Dennis
-
Publication number: 20150378742Abstract: An extensible software application utilizes rules to initiate a behavior that performs operations that customize the extensible software application in a preferred manner. The behavior is applied when pre-defined events occur during execution of the extensible software application. The rules are provided by a third party developer in metadata that is separate from the extension's program code. The rules are based on expressions that define the events that need to take place during the execution of the extensible software application before the behavior is applied.Type: ApplicationFiled: June 30, 2014Publication date: December 31, 2015Inventor: PAUL HARRINGTON
-
Patent number: 9096559Abstract: The present invention relates to a novel class of 4-carboxybenzylamino derivatives. The 4-carboxybenzylamino compounds can be used to treat cancer. The 4-carboxybenzylamino compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of neoplastic cells, thereby inhibiting proliferation of such cells. Thus, the compounds of the present invention are useful in treating a patient having a tumor characterized by proliferation of neoplastic cells. The compounds of the invention may also be useful in the prevention and treatment of TRX-mediated diseases, such as autoimmune, allergic and inflammatory diseases, and in the prevention and/or treatment of diseases of the central nervous system (CNS), such as neurodegenerative diseases.Type: GrantFiled: January 28, 2013Date of Patent: August 4, 2015Assignee: Merck Sharp & Dohme Corp.Inventors: Paul Harrington, Richard W. Heidebrecht, Jr., Solomon Kattar, Thomas A. Miller, Karin M. Otte, Phieng Siliphaivanh, Matthew G. Stanton, Paul Tempest, Kevin J. Wilson, David J. Witter
-
Patent number: 8791147Abstract: The present invention relates generally to novel calcimimetic compounds and pharmaceutical compositions comprising them. The invention also relates to methods of treating of diseases or disorders related to the function of the calcium sensing receptor using the compounds represented in Formula (I). Where Cy1 is pyridinonyl, pyridinyl, quinolinyl or 9-ethyl-9H-beta-carbolinyl, each of which optionally substituted and where Cy2 is phenyl naphthyl.Type: GrantFiled: October 7, 2009Date of Patent: July 29, 2014Assignee: Amgen Inc.Inventors: Christopher Fotsch, Paul Harrington
-
Publication number: 20130137690Abstract: The present invention relates to a novel class of 4-carboxybenzylamino derivatives. The 4-carboxybenzylamino compounds can be used to treat cancer. The 4-carboxybenzylamino compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of neoplastic cells, thereby inhibiting proliferation of such cells. Thus, the compounds of the present invention are useful in treating a patient having a tumor characterized by proliferation of neoplastic cells. The compounds of the invention may also be useful in the prevention and treatment of TRX-mediated diseases, such as autoimmune, allergic and inflammatory diseases, and in the prevention and/or treatment of diseases of the central nervous system (CNS), such as neurodegenerative diseases.Type: ApplicationFiled: January 28, 2013Publication date: May 30, 2013Inventors: Paul Harrington, Richard W. Heidebrecht, JR., Solomon Kattar, Thomas A. Miller, Karin M. Otte, Phieng Siliphaivanh, Matthew G. Stanton, Paul Tempest, Kevin J. Wilson, David J. Witter
-
Patent number: 8389553Abstract: The present invention relates to a novel class of 4-carboxybenzylamino derivatives. The 4-carboxybenzylamino compounds can be used to treat cancer. The 4-carboxybenzylamino compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of neoplastic cells, thereby inhibiting proliferation of such cells. Thus, the compounds of the present invention are useful in treating a patient having a tumor characterized by proliferation of neoplastic cells. The compounds of the invention may also be useful in the prevention and treatment of TRX-mediated diseases, such as autoimmune, allergic and inflammatory diseases, and in the prevention and/or treatment of diseases of the central nervous system (CNS), such as neurodegenerative diseases.Type: GrantFiled: June 24, 2008Date of Patent: March 5, 2013Assignee: Merck Sharp & Dohme Corp.Inventors: Paul Harrington, Solomon Kattar, Thomas A. Miller, Matthew G. Stanton, Paul Tempest, David J. Witter
-
Patent number: 8324396Abstract: The present invention relates generally to compounds represented in Formula I, pharmaceutical compositions comprising them and methods of treating of diseases or disorders related to the function of the calcium sensing receptor. The invention also relates to processes for making such compounds and to intermediates useful in these processes.Type: GrantFiled: July 10, 2008Date of Patent: December 4, 2012Assignee: Amgen Inc.Inventors: Pierre Deprez, Christopher Fotsch, Paul Harrington, Sarah Lively, Kanaka Pattabiraman, David St. Jean, Taoues Temal-Laib
-
Patent number: 8158825Abstract: The present invention relates to a novel class of modified malonate derivatives. The modified malonate compounds can be used to treat cancer. The modified malonate compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of neoplastic cells, thereby inhibiting proliferation of such cells. Thus, the compounds of the present invention are useful in treating a patient having a tumor characterized by proliferation of neoplastic cells. The compounds of the invention may also be useful in the prevention and treatment of TRX-mediated diseases, such as autoimmune, allergic and inflammatory diseases, and in the prevention and/or treatment of diseases of the central nervous system (CNS), such as neurodegenerative diseases.Type: GrantFiled: June 21, 2006Date of Patent: April 17, 2012Assignee: Merck Sharp & Dohme Corp.Inventors: Jonathan Grimm, Paul Harrington, Richard Heidebrecht, Jr., Thomas Miller, Karin Otte, Phieng Siliphaivanh, David Sloman, Matthew Stanton, Kevin Wilson, David Witter, Solomon Kattar, Paul Tempest
-
Publication number: 20110230517Abstract: The present invention relates generally to novel calcimimetic compounds and pharmaceutical compositions comprising them. The invention also relates to methods of treating of diseases or disorders related to the function of the calcium sensing receptor using the compounds represented in Formula (I). Where Cy1 is pyridinonyl, pyridinyl, quinolinyl or 9-ethyl-9H-beta-carbolinyl, each of which optionally substituted and where Cy2 is phenyl naphthyl.Type: ApplicationFiled: October 7, 2009Publication date: September 22, 2011Inventors: Christopher Fotsch, Paul Harrington
-
Publication number: 20100324046Abstract: The present invention relates to a novel class of 4-carboxybenzylamino derivatives. The 4-carboxybenzylamino compounds can be used to treat cancer. The 4-carboxybenzylamino compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of neoplastic cells, thereby inhibiting proliferation of such cells. Thus, the compounds of the present invention are useful in treating a patient having a tumor characterized by proliferation of neoplastic cells. The compounds of the invention may also be useful in the prevention and treatment of TRX-mediated diseases, such as autoimmune, allergic and inflammatory diseases, and in the prevention and/or treatment of diseases of the central nervous system (CNS), such as neurodegenerative diseases.Type: ApplicationFiled: June 24, 2008Publication date: December 23, 2010Inventors: Paul Harrington, Richard W. Heidebrecht, JR., Solomon Kattar, Thomas A. Miller, Karin M. Otte, Phieng Siliphaivanh, Paul Tempest, Kevin J. Wilson, David J. Witter
-
Patent number: D815781Type: GrantFiled: March 23, 2017Date of Patent: April 17, 2018Inventors: John Paul Harrington, Josh Stitzer
-
Patent number: D884910Type: GrantFiled: February 26, 2019Date of Patent: May 19, 2020Assignee: AVATION MEDICAL, INC.Inventors: Jill F. Schiaparelli, Francis Paul Harrington, Serge Roux, Benjamin Zwillinger, Anna Christina Miller, Alireza Mashal, Joyce Chien Tu
-
Patent number: D885594Type: GrantFiled: February 26, 2019Date of Patent: May 26, 2020Assignee: AVATION MEDICAL, INC.Inventors: Jill F. Schiaparelli, Francis Paul Harrington, Serge Roux, Benjamin Zwillinger, Anna Christina Miller, Alireza Mashal, Joyce Chien Tu